Oncologists Accepting UMR in MassachusettsPage 4

Matthew Yurgelun, M.D.

Director, Lynch Syndrome Center; Senior Physician, Dana-Farber Cancer Institute

Oncology

Marlise Luskin, M.D.

Assistant Professor of Medicine, Harvard Medical School; Senior Physician, Dana-Farber Cancer Institute; Educational Director, Adult Leukemia Program, Dana-Farber Cancer Institute; Associate Program Director, Dana-Farber/Mass General Brigham Hematology/Oncology Fellowship Program

Oncology

Laura Dominici, M.D.

Associate Professor of Surgery, Harvard Medical School

Oncology

Colleen Feltmate, MD

Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. Her research interests include ovarian cancer, cervical dysplasia

Oncology

Pasi Antero Janne, MD PHD

Senior Vice President for Translational Medicine; Scientific Director, Belfer Center for Applied Cancer Science; Professor of Medicine, Harvard Medical School

Oncology

Robert Lindsley, MD, PHD

Associate Professor of Medicine, Harvard Medical School; Director, Edward P. Evans Center for Myelodysplastic Syndrome; Director of Clinical Genomics in Hematologic Malignancies

Oncology

David Kwiatkowski, MD

Professor of Medicine at Harvard Medical School, and Senior Physician at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. He earned a BSc from Caltec; Senior Physician

Oncology

Jeffrey Clark, MD

Associate Professor, Medicine, Harvard Medical School

Oncology

Lecia Sequist, MD

Associate Professor of Medicine, Harvard Medical School; Mary B. Saltonstall Endowed Chair in Oncology, Massachusetts General Hospital Cancer Center

Oncology

Alicia Morgans, MD

Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported; Director, Survivorship Program

Oncology

Frank Hodi, MD

Professor of Medicine, Harvard Medical School; Director, Melanoma Center and Center for Immuno-Oncology, Dana-Farber Brigham Cancer Center

Oncology

Craig Bunnell, MD

Chief Medical Officer of the Dana-Farber Cancer Institute, an NCI-designated Comprehensive Cancer Center and Harvard Medical School-affiliated teaching hos; Associate Professor of Medicine at Harvard Medical School. He has been the principal investigator of several institutional and multicenter clinical trials and serves on

Oncology

Justine Cohen, DO

Senior Physician; Assistant Professor of Medicine, Harvard Medical School

Oncology

Florian Fintelmann, M.D.

Associate Professor of Radiology, Harvard Medical School; Director, Thoracic Percutaneous Ablation Program, Massachusetts General Hospital

Oncology

Haeseong Park, MD

Medical Oncology

Oncology

Lakshmi Nayak, M.D.

Director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute in Boston. She is an Associate Professor of Neurology at Harvard Medical School. She r; Director of the Center for Central Nervous System (CNS) Lymphoma

Oncology

Omar Nadeem, M.D.

Senior Physician, Assistant Professor of Medicine at Harvard Medical School

Oncology

Ephraim Hochberg, MD

Oncology

Richard Penson, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Medical Gynecologic Oncology, Massachusetts General Hospital

Oncology

Elad Sharon, M.D.

Director of the Immunotherapy Toxicity Program and a Member of the Faculty of Medicine at Harvard Medical School. From 2011 through August 2023, Dr. Sha

Oncology